TILLOTTS PHARMA UK LIMITED
Get an alert when TILLOTTS PHARMA UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2027-03-25 (in 10mo)
Last made up 2026-03-11
Watchouts
None on the register
Cash
£10M
+41.9% vs 2024
Net assets
£13M
+19.8% vs 2024
Employees
41
0% vs 2024
Profit before tax
£3M
+10.9% vs 2024
Net assets
7-year trend · vs Industrials median
Accounts
7-year trend · latest reflected 2025-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | £57,780,298 | £62,151,963 | |
| Operating profit | — | — | — | — | — | £2,595,972 | £2,889,372 | |
| Profit before tax | — | — | — | — | — | £2,567,210 | £2,846,547 | |
| Net profit | — | — | — | — | — | £1,926,892 | £2,134,989 | |
| Cash | — | — | — | — | — | £7,000,627 | £9,933,841 | |
| Total assets less current liabilities | — | — | — | — | — | £10,773,166 | £12,908,155 | |
| Net assets | — | — | — | — | — | £10,773,166 | £12,908,155 | |
| Equity | £4,030,311 | £5,196,165 | £6,325,749 | £7,558,055 | £8,846,274 | £10,773,166 | £12,908,155 | |
| Average employees | — | — | — | — | — | 41 | 41 | |
| Wages | — | — | — | — | — | £3,313,221 | £3,299,467 | |
| Directors' remuneration | — | — | — | — | — | £353,478 | £363,321 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31
-
Turnover
+7.6%
£57,780,298 £62,151,963
-
Cash
+41.9%
£7,000,627 £9,933,841
-
Net assets
+19.8%
£10,773,166 £12,908,155
-
Employees
0%
41 41
-
Operating profit
+11.3%
£2,595,972 £2,889,372
-
Profit before tax
+10.9%
£2,567,210 £2,846,547
-
Wages
-0.4%
£3,313,221 £3,299,467
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | 4.5% | 4.6% | |
| Net margin | — | — | — | — | — | 3.3% | 3.4% | |
| Return on capital employed | — | — | — | — | — | 24.1% | 22.4% | |
| Current ratio | — | — | — | — | — | 1.47x | 1.40x | |
| Interest cover | — | — | — | — | — | 39.56x | 36.69x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Wright Vigar Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ROBINSON, Lisa | Secretary | 2020-03-16 | — | — |
| BIRD & BIRD COMPANY SECRETARIES LIMITED | Corporate Secretary | 2025-03-19 | — | — |
| HILL, Adrian Steventon | Director | 2025-03-19 | Feb 1970 | British |
| ROBINSON, Lisa | Director | 2024-03-18 | Mar 1979 | British |
| THORPE, Jeremy | Director | 2013-05-14 | May 1963 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JOHNSON, Helen Louise | Secretary | 2016-08-03 | 2020-03-16 |
| ALDBURY SECRETARIES LIMITED | Corporate Secretary | 2010-03-11 | 2016-08-03 |
| CAMBRIDGE, Allan Charles | Director | 2010-03-11 | 2012-08-29 |
| EBERLE, Ingrid | Director | 2018-01-02 | 2019-09-01 |
| JOHNSON, Helen Louise | Director | 2019-04-01 | 2019-10-31 |
| KESCH, Yves | Director | 2016-03-31 | 2018-01-02 |
| LANGE, Barbara, Dr | Director | 2020-03-27 | 2024-02-28 |
| NORRMAN, Olof Mattias | Director | 2010-03-11 | 2022-03-25 |
| PORTMANN, Marcel Paul | Director | 2022-03-25 | 2024-08-31 |
| TOTH VON KISKER, Thomas Alexander | Director | 2010-03-11 | 2016-03-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Zeria Pharmaceutical Co.,Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-03-05 | Active |
Filing timeline
Last 20 of 75 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-24 | AA | accounts | Accounts with accounts type full | |
| 2026-03-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-08 | AA | accounts | Accounts with accounts type full | |
| 2025-03-21 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-03-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-19 | CH01 | officers | Change person director company with change date | |
| 2025-03-19 | AD03 | address | Move registers to sail company with new address | |
| 2025-03-19 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2025-03-19 | AD02 | address | Change sail address company with new address | |
| 2025-03-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-03 | AA | accounts | Accounts with accounts type full | |
| 2024-03-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-05 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-03-05 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2023-03-30 | AA | accounts | Accounts with accounts type full | |
| 2023-03-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-08 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.